Helen Friis-Mikkelsen and Martin Friis-Mikkelsen will be representing SAXOCON at Pharmapack Europe 2025, stand S23, on 22 &23 January. Stop by our stand and find out how we can help you ensure your packaging is safe and compliant.
Containers and other primary packaging systems for drug products must be designed, tested, and documented as not affecting the safety or quality of the finished product.
Both the EMA and the FDA have increased their focus on nitrosamine impurities in packaging materials. This scrutiny increases the burden on manufacturers to know what their packaging materials are made of, whether they can leach nitrosamines, and how to mitigate potential problems.
Our services, designed and run by our team of experts, provide you with everything you need to establish and document compliance with regulatory requirements for primary packaging, fill in the gaps in your supply chain information, and assess your packaging and storage processes for the presence of nitrosamines.
Find out more about our pharmaceutical services here.